Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GOSS
Stock Latest News
Market News
3 Best Stocks to Buy Now, 9/26/2025, According to Top Analysts
1d ago
DEFT
GOSS
Premium
Company Announcements
Gossamer Bio Enters Merger Agreement with Respira
2d ago
8K
GOSS
Premium
The Fly
Gossamer Bio signs option to acquire Respira Therapeutics
2d ago
GOSS
Premium
The Fly
Gossamer Bio to acquire Respira Therapeutics in all-stock transaction
2d ago
GOSS
Premium
The Fly
Largest borrow rate increases among liquid names
3d ago
BNC
NFE
Premium
Ratings
Gossamer Bio’s Seralutinib: Promising Advancements in PAH Treatment Reinforce Buy Rating
12d ago
GOSS
Premium
The Fly
Cantor says has reinforced conviction on Gossamer Bio ahead of data readout
16d ago
GOSS
Premium
The Fly
Gossamer Bio upgraded to Buy from Neutral at UBS
17d ago
GOSS
Premium
Ratings
Gossamer Bio’s Seralutinib: Promising Long-Term Therapy with Upcoming Catalysts
1M ago
GOSS
Premium
Company Announcements
Gossamer Bio Reports Q2 2025 Financial Results
2M ago
GOSS
Premium
Ratings
Gossamer Bio’s Promising Clinical Advancements and Strategic Positioning Earns Buy Rating
2M ago
GOSS
Premium
The Fly
Gossamer Bio reports Q2 EPS (17c) , consensus (18c)
2M ago
GOSS
Premium
The Fly
Gossamer Bio initiated with an Outperform at Scotiabank
3M ago
GOSS
Premium
Company Announcements
Gossamer Bio Approves 2019 Incentive Award Plan
3M ago
8K
GOSS
Premium
Ratings
Optimistic Buy Rating for Gossamer Bio Amid Strong Phase 3 PROSERA Study Progress and Competitive Landscape
3M ago
GOSS
Premium
Company Announcements
Gossamer Bio Completes Enrollment for Phase 3 Study
3M ago
8K
GOSS
Premium
The Fly
Gossamer Bio completes enrollment in PROSERA study
3M ago
GOSS
Premium
Ratings
Gossamer Bio’s Promising Clinical Advances and Strong Financial Position Justify Buy Rating
4M ago
GOSS
Premium
Ratings
Optimistic Growth Prospects for Gossamer Bio Amid Strategic Advances and Study Alignments
4M ago
GOSS
Premium
Company Announcements
Gossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves
4M ago
GOSS
Premium
Company Announcements
Gossamer Bio Reports Q1 2025 Results and Study Updates
4M ago
GOSS
Premium
The Fly
Gossamer Bio reports Q1 EPS (16c), consensus (19c)
4M ago
GOSS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
